SIREN : 510637655
SELARL CLINIQUE MICHEL BARON is a French company founded 17 years ago, specialized in the sector Activités vétérinaires. Based in CRETEIL (94000), this company of category PME shows in 2024 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2021 | 2020 | 2019 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 1 548 669 € | 1 469 701 € | 1 479 652 € | 1 296 885 € | 1 215 294 € | 1 159 141 € | 1 172 370 € |
| Net income | 249 890 € | 161 994 € | 160 812 € | 109 357 € | 29 687 € | 49 448 € | 33 661 € |
| EBITDA | 395 409 € | 289 583 € | 298 300 € | 234 451 € | 147 496 € | 152 905 € | 138 666 € |
| Net margin | 16.1% | 11.0% | 10.9% | 8.4% | 2.4% | 4.3% | 2.9% |
In 2024, SELARL CLINIQUE MICHEL BARON achieves revenue of 1.5 M€. Revenue is growing positively over 7 years (CAGR: +3.5%). Vs 2023: +5%. After deducting consumption (-13 k€), gross margin stands at 1.6 M€, i.e. a rate of 101%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 395 k€, representing 25.5% of revenue. Positive scissor effect: EBITDA margin improves by +5.8 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 250 k€, i.e. 16.1% of revenue. This profit can be retained or distributed to shareholders.
1 548 669 €
1 561 250 €
395 409 €
328 219 €
249 890 €
25.5%
The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 20.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
79.635%
46.378%
20.41%
0.93
4.7%
In 2024, the debt ratio of SELARL CLINIQUE MICHEL BARON (79.64) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of SELARL CLINIQUE MICHEL BARON (46.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of SELARL CLINIQUE MICHEL BARON (0.93) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 408.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.5x. Danger: operating income does not cover interest charges, unsustainable situation.
408.265
0.452
In 2024, the liquidity ratio of SELARL CLINIQUE MICHEL BARON (408.26) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of SELARL CLINIQUE MICHEL BARON (0.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 35 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 17 days. The company must finance 18 days of gap between collections and payments. Inventory turnover is 35 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 56 days of revenue, i.e. 242 k€ to permanently finance. Over 2016-2024, WCR increased by +645%, requiring additional financing.
242 072 €
35 j
17 j
35 j
56 j
Compare SELARL CLINIQUE MICHEL BARON with other companies in the same sector:
Voir toutes les statistiques du secteur Activités vétérinaires
The revenue of SELARL CLINIQUE MICHEL BARON in 2024 is 1.5 M€.
Yes, SELARL CLINIQUE MICHEL BARON generated a net profit of 250 k€ in 2024.
The headquarters of SELARL CLINIQUE MICHEL BARON is located in CRETEIL (94000), in the department Val-de-Marne.
The tax return of SELARL CLINIQUE MICHEL BARON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SELARL CLINIQUE MICHEL BARON operates in the sector Activités vétérinaires (NAF code 75.00Z). See the 'Sector positioning' section above to compare the company with its competitors.